Decibel Therapeutics, Inc. is a Boston-based biotechnology company that is dedicated to addressing the unmet needs of individuals with hearing and balance disorders. With a focus on regenerative and gene therapy strategies, Decibel aims to develop novel therapeutics that can restore hearing and balance, creating meaningful connections for patients and their families.
Driven by a passionate team, Decibel Therapeutics is at the forefront of fueling a new field in drug development. Through their pipeline of innovative approaches, including genetic testing resources, the company is committed to making a significant impact in the lives of those affected by hearing and balance disorders.
Generated from the website